Drawing for KNOX MEDICAL

USPTO serial 87451183

KNOX MEDICAL

Reviewed by CopyMark Law Group

Reg. 5557249Status 710
Filing date
Status date
Registration date
Sep 4, 2018
Examiner
BEN, LINDSEY HEATHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KNOX MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frank Robison

Frank Robison Robison Law LLC2043 Buchanan PointLafayette, CO 80026UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; none of the forgoing containing marijuana or extracts therefromSECTION 8 - CANCELLEDDec 9, 2016
035Retail drug store and pharmaceutical dispensary services that not do not feature goods containing cannabinoids or cannabisSECTION 8 - CANCELLEDDec 9, 2016
042Product research and development, not including marijuana or extracts therefromSECTION 8 - CANCELLEDDec 9, 2016
044Providing health information in the field of medical marijuana and regarding the indications and effects of particular cannabinoids; providing information pertaining to the benefits of the medicinal use of cannabis to treat certain ailmentsSECTION 8 - CANCELLEDDec 9, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2025C8..CANCELLED SEC. 8 (6-YR)—
Sep 4, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 26, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 4, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jul 30, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 17, 2018CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jul 17, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jul 17, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 17, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 17, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 22, 2018ALIEASSIGNED TO LIE—
Jun 8, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 18, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 11, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2017DOCKASSIGNED TO EXAMINER—
Jun 1, 2017DOCKASSIGNED TO EXAMINER—
May 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance